Viewing Study NCT03441100

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-26 @ 12:18 PM
Ignite Modification Date: 2026-03-07 @ 9:04 AM
Study NCT ID: NCT03441100
Status: COMPLETED
Last Update Posted: 2025-02-04
First Post: 2018-02-09
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: TCR-engineered T Cells in Solid Tumors: IMA202-101
Sponsor: Immatics US, Inc.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Solid Tumor, Adult View
None Refractory Cancer View
None Recurrent Cancer View
None Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None T-Cell therapy View
None Immunotherapy View
None Adoptive cellular therapy View
None T-Cell Receptor View
None Cell Therapy View
None Cytotherapy View
None IMA202 View